|
| Age ≤ 50 | Test value | p-value | Sig. | ||||
| Group I | Group II | |||||||
| No. =18 | % | No. =110 | % | |||||
| ER | Negative | 5 | 27.8% | 27 | 24.5% | 0.048 | 0.827 | NS |
| Positive | 13 | 72.2% | 83 | 75.5% | ||||
| PR | Negative | 5 | 27.8% | 30 | 27.3% | 0.188 | 0.664 | NS |
| Positive | 13 | 72.2% | 80 | 72.3% | ||||
| HER/2 | Negative | 12 | 66.7% | 76 | 69.1% | 0.021 | 0.884 | NS |
| Positive | 6 | 33.3% | 34 | 30.1% | ||||
| Luminal subtype | HR+/Her2− | 9 | 50.0% | 58 | 52.7% | 1.758 | 0.176 | NS |
| HR+/Her2+ | 4 | 22.2% | 26 | 23.6% | ||||
| Her+ | 1 | 5.6% | 10 | 9.1% | ||||
| TN | 4 | 22.2% | 16 | 14.6% | ||||